Department of Laboratory, Shandong University Hospital, Jinan, Shandong, China.
Department of Gastroenterology, Taishan Sanatorium of Shandong Province, Tai'an, Shandong, China.
Cell Cycle. 2020 Mar;19(5):601-609. doi: 10.1080/15384101.2020.1728017. Epub 2020 Feb 20.
MAFG antisense 1 (MAFG-AS1) is recently identified as a novel lncRNA and serves as a tumor promoter in several types of human tumor. However, no prior study has been performed to evaluate the role of MAFG-AS1 in gastric cancer. In our study, we found MAFG-AS1 expression was increased in gastric cancer tissue samples compared with normal gastric mucosa tissue samples, and associated with poor overall survival in gastric cancer patients at The Cancer Genome Atlas database. Furthermore, we confirmed the clinical and prognostic significance of MAFG-AS1 in gastric cancer. We found gastric cancer tissues and cell lines had remarkably increased MAFG-AS1 expression in comparison to normal gastric mucosa tissues and normal human gastric epithelial cell line, and high MAFG-AS1 expression was positively associated with diffuse type, advanced clinical stage, extensive depth of invasion, more lymph node metastasis, and present distant metastasis in gastric cancer patients. Moreover, high MAFG-AS1 expression acted as one of the independent poor prognostic factors for overall survival in gastric cancer patients. The loss-of-function study showed knocking down MAFG-AS1 expression inhibited gastric cancer cell proliferation, migration and invasion . In conclusion, MAFG-AS1 is probable to be a valuable prognostic biomarker, and a novel potential target for gastric cancer.
MAFG 反义 1(MAFG-AS1)最近被鉴定为一种新型 lncRNA,在几种人类肿瘤中作为肿瘤促进物发挥作用。然而,之前没有人研究过 MAFG-AS1 在胃癌中的作用。在我们的研究中,我们发现与正常胃黏膜组织样本相比,胃癌组织样本中 MAFG-AS1 的表达增加,并且与癌症基因组图谱数据库中胃癌患者的总生存率降低相关。此外,我们还证实了 MAFG-AS1 在胃癌中的临床和预后意义。我们发现与正常胃黏膜组织和正常人类胃上皮细胞系相比,胃癌组织和细胞系中 MAFG-AS1 的表达显著增加,并且高 MAFG-AS1 表达与弥漫型、晚期临床分期、广泛的浸润深度、更多的淋巴结转移和目前的远处转移呈正相关。此外,高 MAFG-AS1 表达是胃癌患者总生存率的独立预后不良因素之一。功能丧失研究表明,下调 MAFG-AS1 表达抑制了胃癌细胞的增殖、迁移和侵袭。总之,MAFG-AS1 可能是一种有价值的预后生物标志物,也是胃癌的一个新的潜在治疗靶点。